A CDK1 phospho-switch reprograms TRAIP to unload replisomes in mitosis
Science · 13.08.2026 · 393 (6812)
DOI: 10.1126/science.aeh1834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 13.08.2026. Verfasst von Geylani Can und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: CDC2 Protein Kinase, DNA Polymerase II, DNA Replication, DNA-Binding Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Institutes of Health, Howard Hughes Medical Institute, American Association for Cancer Research.
Abstract (Originalsprache)
Cells entering mitosis with incompletely replicated DNA face catastrophic chromosome segregation failure. During interphase, the replisome-associated E3 ubiquitin ligase TRAIP ubiquitylates barriers in front of the fork to allow replisome progression. In mitosis, TRAIP is reprogrammed from a trans-acting to a cis-acting ligase that can ubiquitylate the replisome itself. This enables the processing of unreplicated DNA by promoting replisome disassembly, fork breakage, and joining of the broken chromosome arms. Here, we describe a mechanism for this reprogramming: The adenosine triphosphatase transcription termination factor 2 (TTF2) is recruited to the replisome, where its noncatalytic N-terminal domain tethers cyclin B-cyclin–dependent kinase 1–phosphorylated TRAIP to the leading strand DNA polymerase ε in a geometry that allows replisome ubiquitylation. Thus, a phosphoregulated architectural switch alters replisome organization in mitosis to safeguard genome integrity before chromosome segregation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, and Boston Children's Hospital, Boston, MA, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
- Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
- Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, USA.
- Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
ORCID-Profile: Geylani Can, Maksym Shyian, Archana Krishnamoorthy, Samreen Ahmed, Yang Lim, Raphael Pavani, André Nussenzweig, Markus Räschle, Thomas E Wilson, Thomas W Glover, Johannes C Walter, David Pellman
Förderung
- National Institutes of Health
- Howard Hughes Medical Institute
- American Association for Cancer Research
- American Cancer Society
- Damon Runyon Cancer Research Foundation
- Lustgarten Foundation
- Swiss National Science Foundation
- William W. Wellington Memorial Research Fund
Zitieren
APA
Can, G., Shyian, M., Krishnamoorthy, A., Ahmed, S., Lim, Y., Wu, A., Pavani, R., Zaher, M. S., Nussenzweig, A., Räschle, M., Wilson, T. E., Glover, T. W., Walter, J. C., & Pellman, D. (2026). A CDK1 phospho-switch reprograms TRAIP to unload replisomes in mitosis. Science, 393(6812). https://doi.org/10.1126/science.aeh1834
Vancouver
Can G, Shyian M, Krishnamoorthy A, Ahmed S, Lim Y, Wu A, et al. A CDK1 phospho-switch reprograms TRAIP to unload replisomes in mitosis. Science. 2026;393(6812). doi:10.1126/science.aeh1834
BibTeX
@article{Can2026,
author = {Can, Geylani and Shyian, Maksym and Krishnamoorthy, Archana and Ahmed, Samreen and Lim, Yang and Wu, Alex and Pavani, Raphael and Zaher, Manal S and Nussenzweig, André and Räschle, Markus and Wilson, Thomas E and Glover, Thomas W and Walter, Johannes C and Pellman, David},
title = {A CDK1 phospho-switch reprograms TRAIP to unload replisomes in mitosis},
journal = {Science},
year = {2026},
volume = {393},
number = {6812},
doi = {10.1126/science.aeh1834}
}
EUVIMED